Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Shanghai Zhongshan Hospital

14 clinical trials · 14 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Shanghai Zhongshan Hospital

RECRUITINGNCT06705036

Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions

This study involves collecting paired tumor samples from intrasellar and cavernous sinus regions of 20 invasive pituitary tumor patients, preserving them at -80°C for quality...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 201 location
Pituitary Tumor
RECRUITINGNCT06537908

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

This study is being done to analyze the safety, tolerability, and efficacy of treatment using combination of anti-VEGF and anti-PD-1/PDL1 antibodies for patients with advanced...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 501 location
Hepatocellular Carcinoma
RECRUITINGNCT05347524

Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study

This study is a prospective, multi-omics, observational study aimed at detecting peritoneal metastasis of gastric cancer by combined assays for methylation of cell-free DNA...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 3841 location
Cancer
RECRUITINGPhase 2NCT06468280

Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in...

ROSETTE trial is an open-label, randomized phase II study designed to investigate treatment strategies for patients with limited metastatic gastric or gastroesophageal...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 842 locations
Gastric CancerGastroEsophageal Cancer
RECRUITINGPhase 1NCT07317609

Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer...

This single-center, prospective, single-arm study will evaluate whether giving neoadjuvant chemoimmunotherapy can safely shrink esophageal cancer and allow organ-preserving...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 601 location
Esophageal Squamous Cell Carcinoma (ESCC)
RECRUITINGNCT06253962

Carotid Atherosclerosis in Predicting Coronary Artery Disease

Carotid plaque burden and composition features, particularly lipid necrotic core, are significantly associated with severity of CAD stenosis. This study aims to explore the...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 10001 location
Carotid AtherosclerosisCoronary Atheroscleroses
RECRUITINGNCT07116083

µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions

Murray-law based single-view quantitative flow ratio (µQFR) has been recommended for guiding percutaneous coronary intervention (PCI) in selective patients. However, it's...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 2901 location
Coronary Artery DiseaseCoronary Artery Disease (Left Main)Obstructive Coronary Artery Disease+1
RECRUITINGNCT07483125

Valsalva SBP Drop and LVOT Obstruction

This study aimed to evaluate the efficacy of non-invasive dynamic blood pressure monitoring in assessing left ventricular outflow tract obstruction in patients with hypertrophic...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 8001 location
HCMoHCMnHCM
RECRUITINGNCT07145463

Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter...

This is a prospective, multicenter, randomized controlled clinical study designed to evaluate the real-world performance of the VitaFlow Liberty® Flex Transcatheter Aortic Valve...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 2321 location
Aortic Valve Stenosis
RECRUITINGNCT07208006

Very Early PCSK9 Inhibition for Acute Myocardial Infarction

Acute myocardial infarction (AMI) remains a major cause of morbidity and mortality, particularly in patients with multivessel coronary artery disease. Although primary...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 15181 location
Acute Myocardial Infarction (AMI)
RECRUITINGPhase 4NCT06498089

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision...

This study aimed to compare the efficacy and safety of a precision treatment regimen based on clinical-molecular phenotypes with a conventional treatment regimen in the treatment...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 1241 location
Takayasu Arteritis
RECRUITINGPhase 4NCT05102448

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

The aim of this study is to evaluate and compare the efficacy and safety of tofacitinib and methotrexate based on prednisone therapy in patients with Takayasu arteritis

Sponsor: Shanghai Zhongshan HospitalEnrolling: 761 location
Takayasu Arteritis
RECRUITINGPhase 4NCT04300686

A Pilot Study in Severe Patients With Takayasu Arteritis.

Takayasu arteritis (TAK) is a rare chronic inflammatory arteritis, which lacks an effective well-accepted intervention strategy. We classify TAK patients into 3 levels, including...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 401 location
Takayasu ArteritisTocilizumabAdalimumab+1
RECRUITINGEarly Phase 1NCT07261345

Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease

Graves' disease is an autoimmune thyroid disorder in which autoantibodies against the thyroid-stimulating hormone receptor (TRAb) lead to excessive thyroid hormone production and...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 41 location
Graves' Disease